ALIM logo

Alimera Sciences (ALIM) EBIT

Annual EBIT

-$9.86 M
+$2.34 M+19.15%

December 31, 2023

Summary

Performance

1-Year Change

+19.15%

3-Year Change

-36425.93%

5-Year Change

+14.25%

15-Year Change

+39.34%

ALIM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.48 M
ALIM annual earnings before interest & taxes is currently -766.80% below its historical high of $1.48 million

3-Year Low

-$12.20 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ALIM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ALIM next annual earnings announcement has not yet been scheduled

OtherALIMprofitabilitymetrics:

Annual Revenue

$80.75 M
ALIM annual revenue is $80.75 million

Annual Net Income

-$20.13 M
ALIM annual net profit is -$20.13 million

Annual EBITDA

-$1.11 M
ALIM annual EBITDA is -$1.11 million

Annual EPS

-$0.84
ALIM annual earnings per share is -$0.84

Quarterly EBIT

-$201.00 K
+$2.34 M+92.10%

June 30, 2024

Summary

Performance

3-Month Change

+92.1%

1-Year Change

-126.14%

3-Year Change

-102.1%

5-Year Change

+89.02%

ALIM Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.55 M
ALIM quarterly earnings before interest & taxes is currently -102.10% below its historical high of $9.55 million

3-Year Low

-$8.31 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
ALIM previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
ALIM next earnings announcement has not yet been scheduled

OtherALIMprofitabilitymetrics:

Quarterly Revenue

$27.00 M
ALIM quarterly revenue is $27.00 million

Quarterly Net Income

-$3.31 M
ALIM quarterly net profit is -$3.31 million

Quarterly EBITDA

$2.89 M
ALIM quarterly EBITDA is $2.89 million

Quarterly EPS

-$0.06
ALIM quarterly earnings per share is -$0.06

TTM EBIT

-$996.00 K
+$8.11 M+89.06%

June 30, 2024

Summary

Performance

3-Month Change

+89.06%

1-Year Change

+92.33%

3-Year Change

-112.04%

5-Year Change

+81.41%

ALIM TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$8.27 M
ALIM TTM earnings before interest & taxes is currently -112.04% below its historical high of $8.27 million

3-Year Low

-$17.50 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
ALIM previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
ALIM next earnings announcement has not yet been scheduled

OtherALIMprofitabilitymetrics:

TTM Revenue

$99.68 M
ALIM TTM revenue is $99.68 million

TTM Net Income

-$14.70 M
ALIM TTM net profit is -$14.70 million

TTM EBITDA

$11.38 M
ALIM TTM EBITDA is $11.38 million

TTM EPS

-$0.31
ALIM TTM earnings per share is -$0.31

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$9.86 M
ALIM annual earnings before interest & taxes is -$9.86 million

Annual Revenue

$80.75 M
ALIM annual revenue is $80.75 million

Annual Cost Of Goods Sold

$10.84 M
ALIM annual cost of goods sold is $10.84 million

Annual Operating Expenses

$71.85 M
ALIM annual total operating expenses is $71.85 million

ALIM EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+19.1%-126.1%+92.3%
3 y3 years-10000.0%-102.1%-112.0%
5 y5 years+14.3%+89.0%+81.4%

ALIM EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-766.8%+23.7%-120.5%+4034.3%-167.3%+1657.3%
5 y5-year-766.8%+23.7%-102.1%+4034.3%-112.0%+1657.3%
alltimeall time-766.8%+407.8%-102.1%>+9999.0%-112.0%+4928.2%

Alimera Sciences EBIT History

DateAnnualQuarterlyTTM
Jun 2024
-
-$201.00 K(-92.1%)
-$996.00 K(-89.1%)
Mar 2024
-
-$2.54 M(-359.6%)
-$9.11 M(-7.7%)
Dec 2023
-$9.86 M(-19.2%)
$980.00 K(+27.4%)
-$9.86 M(-24.1%)
Sep 2023
-
$769.00 K(-109.3%)
-$12.99 M(-25.8%)
Jun 2023
-
-$8.31 M(+151.7%)
-$17.50 M(+60.5%)
Mar 2023
-
-$3.30 M(+53.7%)
-$10.91 M(-10.6%)
Dec 2022
-$12.20 M(-924.7%)
-$2.15 M(-42.7%)
-$12.20 M(-4.9%)
Sep 2022
-
-$3.75 M(+118.4%)
-$12.83 M(+6.2%)
Jun 2022
-
-$1.72 M(-62.6%)
-$12.07 M(+1396.2%)
Mar 2022
-
-$4.59 M(+65.4%)
-$807.00 K(-154.6%)
Dec 2021
$1.48 M(-5577.8%)
-$2.78 M(-7.2%)
$1.48 M(-67.9%)
Sep 2021
-
-$2.99 M(-131.3%)
$4.61 M(-44.3%)
Jun 2021
-
$9.55 M(-514.4%)
$8.27 M(-435.1%)
Mar 2021
-
-$2.31 M(-754.8%)
-$2.47 M(+9044.4%)
Dec 2020
-$27.00 K(-99.5%)
$352.00 K(-47.8%)
-$27.00 K(-102.5%)
Sep 2020
-
$674.00 K(-156.6%)
$1.10 M(-178.2%)
Jun 2020
-
-$1.19 M(-968.6%)
-$1.41 M(-62.6%)
Mar 2020
-
$137.00 K(-90.7%)
-$3.76 M(-29.9%)
Dec 2019
-$5.36 M(-53.4%)
$1.48 M(-180.7%)
-$5.36 M(-21.7%)
Sep 2019
-
-$1.83 M(-48.3%)
-$6.85 M(-5.3%)
Jun 2019
-
-$3.54 M(+141.9%)
-$7.23 M(+12.4%)
Mar 2019
-
-$1.46 M(>+9900.0%)
-$6.43 M(-44.1%)
Dec 2018
-$11.50 M(-29.3%)
-$11.00 K(-99.5%)
-$11.50 M(-33.2%)
Sep 2018
-
-$2.21 M(-19.5%)
-$17.22 M(-8.6%)
Jun 2018
-
-$2.75 M(-58.0%)
-$18.84 M(+8.1%)
Mar 2018
-
-$6.53 M(+14.1%)
-$17.42 M(+7.1%)
Dec 2017
-$16.26 M(-41.6%)
-$5.73 M(+49.5%)
-$16.26 M(+2.4%)
Sep 2017
-
-$3.83 M(+188.3%)
-$15.87 M(-17.7%)
Jun 2017
-
-$1.33 M(-75.3%)
-$19.29 M(-21.0%)
Mar 2017
-
-$5.37 M(+0.6%)
-$24.41 M(-12.3%)
Dec 2016
-$27.82 M(+7.8%)
-$5.34 M(-26.2%)
-$27.82 M(+45.9%)
Sep 2016
-
-$7.24 M(+12.3%)
-$19.07 M(-5.9%)
Jun 2016
-
-$6.45 M(-26.6%)
-$20.27 M(-14.2%)
Mar 2016
-
-$8.79 M(-357.3%)
-$23.62 M(-8.5%)
Dec 2015
-$25.82 M
$3.42 M(-140.5%)
-$25.82 M(-36.8%)
DateAnnualQuarterlyTTM
Sep 2015
-
-$8.44 M(-13.8%)
-$40.86 M(-0.4%)
Jun 2015
-
-$9.80 M(-10.9%)
-$41.04 M(+10.3%)
Mar 2015
-
-$10.99 M(-5.4%)
-$37.20 M(+10.6%)
Dec 2014
-$33.65 M(-26.4%)
-$11.62 M(+34.7%)
-$33.65 M(-20.6%)
Sep 2014
-
-$8.63 M(+44.8%)
-$42.37 M(+2.2%)
Jun 2014
-
-$5.96 M(-20.0%)
-$41.46 M(-7.5%)
Mar 2014
-
-$7.44 M(-63.4%)
-$44.84 M(-1.8%)
Dec 2013
-$45.70 M(+141.1%)
-$20.34 M(+163.7%)
-$45.66 M(+50.0%)
Sep 2013
-
-$7.72 M(-17.4%)
-$30.44 M(+9.0%)
Jun 2013
-
-$9.34 M(+13.1%)
-$27.93 M(+21.0%)
Mar 2013
-
-$8.26 M(+61.0%)
-$23.08 M(+21.8%)
Dec 2012
-$18.96 M(-11.4%)
-$5.13 M(-1.5%)
-$18.95 M(-3.5%)
Sep 2012
-
-$5.21 M(+15.9%)
-$19.64 M(-5.1%)
Jun 2012
-
-$4.49 M(+8.8%)
-$20.68 M(-2.0%)
Mar 2012
-
-$4.13 M(-29.0%)
-$21.12 M(-1.3%)
Dec 2011
-$21.39 M(-3.1%)
-$5.81 M(-7.1%)
-$21.40 M(-1.1%)
Sep 2011
-
-$6.26 M(+27.1%)
-$21.64 M(+0.6%)
Jun 2011
-
-$4.92 M(+11.6%)
-$21.50 M(-3.5%)
Mar 2011
-
-$4.41 M(-27.0%)
-$22.27 M(+0.9%)
Dec 2010
-$22.07 M(+14.9%)
-$6.04 M(-1.2%)
-$22.07 M(+8.3%)
Sep 2010
-
-$6.12 M(+7.5%)
-$20.37 M(+7.9%)
Jun 2010
-
-$5.69 M(+35.0%)
-$18.89 M(+5.3%)
Mar 2010
-
-$4.22 M(-3.0%)
-$17.94 M(-6.6%)
Dec 2009
-$19.22 M(-61.6%)
-$4.34 M(-6.2%)
-$19.22 M(-11.2%)
Sep 2009
-
-$4.63 M(-2.4%)
-$21.63 M(-2.8%)
Jun 2009
-
-$4.75 M(-13.5%)
-$22.26 M(+1.0%)
Mar 2009
-
-$5.49 M(-18.8%)
-$22.05 M(-56.0%)
Dec 2008
-$50.08 M(+300.1%)
-$6.76 M(+28.4%)
-$50.08 M(+15.6%)
Sep 2008
-
-$5.26 M(+16.0%)
-$43.32 M(+13.8%)
Jun 2008
-
-$4.54 M(-86.5%)
-$38.06 M(+3.9%)
Mar 2008
-
-$33.52 M(+972.4%)
-$36.65 M(+501.0%)
Dec 2007
-$12.52 M(+20.6%)
-
-
Jun 2007
-
-$3.13 M(+5.2%)
-$6.10 M(+105.2%)
Mar 2007
-
-$2.97 M
-$2.97 M
Dec 2006
-$10.38 M
-
-

FAQ

  • What is Alimera Sciences annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Alimera Sciences?
  • What is Alimera Sciences annual EBIT year-on-year change?
  • What is Alimera Sciences quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Alimera Sciences?
  • What is Alimera Sciences quarterly EBIT year-on-year change?
  • What is Alimera Sciences TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Alimera Sciences?
  • What is Alimera Sciences TTM EBIT year-on-year change?

What is Alimera Sciences annual earnings before interest & taxes?

The current annual EBIT of ALIM is -$9.86 M

What is the all time high annual EBIT for Alimera Sciences?

Alimera Sciences all-time high annual earnings before interest & taxes is $1.48 M

What is Alimera Sciences annual EBIT year-on-year change?

Over the past year, ALIM annual earnings before interest & taxes has changed by +$2.34 M (+19.15%)

What is Alimera Sciences quarterly earnings before interest & taxes?

The current quarterly EBIT of ALIM is -$201.00 K

What is the all time high quarterly EBIT for Alimera Sciences?

Alimera Sciences all-time high quarterly earnings before interest & taxes is $9.55 M

What is Alimera Sciences quarterly EBIT year-on-year change?

Over the past year, ALIM quarterly earnings before interest & taxes has changed by -$970.00 K (-126.14%)

What is Alimera Sciences TTM earnings before interest & taxes?

The current TTM EBIT of ALIM is -$996.00 K

What is the all time high TTM EBIT for Alimera Sciences?

Alimera Sciences all-time high TTM earnings before interest & taxes is $8.27 M

What is Alimera Sciences TTM EBIT year-on-year change?

Over the past year, ALIM TTM earnings before interest & taxes has changed by +$11.99 M (+92.33%)